Delivery Order SPE2DB20D1100-SPE2DB25FD2B9

Award Date 7/2/25
Potential Completion Date 7/3/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Opzelura 1.5% cream in 60-gram units. The contract has a firm fixed price of $4,315.84 and an ultimate completion date of May 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,335.40, is for the delivery of Opzelura 1.5% cream, a pharmaceutical product, to DLA. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 9, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a Defense agency, to provide Opzelura 1.5% cream 60 gm. The firm-fixed-price contract has a ceiling value of $12,162.44 and an ultimate completion date of May 8, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,493.04, is for the delivery of Opzelura 1.5% Cream in 60g quantities. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is October 27, 2023. The contract does not have a set-aside designation, indicating open...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide 4567504104 OPZELURA 1.5% CREAM 60GM. The fixed-price contract has a ceiling value of $3,908.60 and a period of performance through March 10, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to supply a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,330.79, is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract has a performance period through May 12, 2023 and is a Firm Fixed Price type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,922.26, is for the delivery of the prescription medication Opzelura 1.5% Cream 60GM. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania, holds a significant Indefinite...
This is a delivery order issued under contract SPE2DX15D3108 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Opzelura 1.5% cream, a prescription medication, with a ceiling value of $5,498.88. The contract has a period of performance through September 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order, valued at $4,561.96, is for the supply of Opzelura 1.5% cream, a specialty pharmaceutical product. The order was placed against an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract is valued at up to $6,221.38 and covers the delivery of OPZELURA 1.5% Cream 60GM, a pharmaceutical product. This order falls under Amerisourcebergen's single-award IDC with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FD2B9
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,521.55, is for the supply of Opzelura 1.5% cream in 60 gram quantities. It is a firm fixed-price contract with a performance period through July 3, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely part of that broader IDC, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, as the prime contractor, has demonstrated its ability to fulfill varied federal medical supply requirements through its extensive track record of DLA delivery orders for both brand-name and generic medications across multiple therapeutic areas.

Generated 10/1/25, 10:01 AM